Search by therapeutic area for drugs approved by the Food and Drug Administration (FDA) for sale in the
United States. Click on an area below to view the complete list of drugs in that category or
review descriptions for our therapeutic
area list to assist you in your search.
FDA Approved Drugs for Otolaryngology (Ear, Nose, Throat)
Drugs Approved in 2012
Dymista (azelastine hydrochloride and fluticasone propionate); Meda Pharmaceuticals Inc.;
For the relief of symptoms of seasonal allergic rhinitis, Approved May 2012
Qnasl (beclomethasone dipropionate) nasal aerosol; Teva Pharmaceutical;
For the treatment of seasonal and perennial allergic rhinitis, Approved March 2012
Drugs Approved in 2011
Vandetanib (vandetanib); AstraZeneca;
For the treatment of thyroid cancer, Approved April 2011
Drugs Approved in 2010
Oravig (miconazole); Strativa Pharmaceuticals;
oropharyngeal candidiasis, Approved April 2010
Drugs Approved in 2008
Astepro (azelastine hydrochloride nasal spray); Meda Pharmaceuticals Inc.;
For the treatment of seasonal and perennial allergic rhinitis, Approved October 2008
Moxatag (amoxicillin); MiddleBrooke Pharmaceuticals;
For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics, Approved January 2008
Patanase (olopatadine hydrochloride); Alcon;
For the treatment of seasonal allergic rhinitis, Approved April 2008
Drugs Approved in 2007
Veramyst (fluticasone furoate); GlaxoSmithKline;
For the treatment of seasonal and perennial allergic rhinitis, Approved April 2007
Xyzal (levocetirizine dihydrochloride); UCB;
For the treatment of seasonal and perennial allergic rhinitis and urticaria, Approved May 2007
Drugs Approved in 2000
Depakote ER (divalproex sodium); Abbott Laboratories;
For the prophylaxis (prevention) of migraine headaches in adults, Approved August 2000
Protonix (pantoprazole sodium) Delayed-Release Tablets; Wyeth;
For treatment of erosive esophagitis, Approved February 2000
Tri-Nasal Spray (triamcinolone acetonide spray); Muro Pharmaceutical;
For treatment of nasal symptoms of allergic rhinitis in adults and children age 12 or older, Approved February 2000
Drugs Approved in 1999
Ethyol (amifostine); U.S. Bioscience, Alza;
Treatment for xerostomia (dry mouth) due to radiation, Approved June 1999
Drugs Approved in 1998
Rocephin; Roche;
Treatment for pediatric otitis media, Approved January 1998
Drugs Approved in 1997
Floxin otic; Daiichi Sankyo;
Treatment for otitis media, Approved December 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Drugs Approved in 1996
Bactroban Nasal 2% (mupirocin calcium ointment); SmithKline Beecham;
Treatment for nasal bacteria, Approved April 1996
Drugs Approved in 1995
Cedax (ceftibuten); Schering-Plough;
Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis, Approved December 1995
